Larry Alexander
About Larry Alexander
Larry Alexander (age 45) is an independent director of Inspire Veterinary Partners (IVP) who has served on the Board since August 2023. He is Vice President of Operations at CarepathRx (since January 2022), with prior experience as Managing Director at First Financial Bank (2017–2021) and leadership roles at McKesson (2002–2017; most recently VP, Strategic Solutions & National Accounts). He holds a B.S. in Industrial Distribution (Texas A&M University, May 2002). His background emphasizes multi‑billion‑dollar negotiations, facilitating M&A, and growth-focused operations leadership across public and private enterprises .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| CarepathRx | Vice President of Operations | Jan 2022–present | Senior operator; growth and culture focus |
| First Financial Bank | Managing Director | Sep 2017–Dec 2021 | Senior leadership; business development |
| McKesson Corporation | VP, Strategic Solutions & National Accounts; other roles | Jan 2010–Aug 2017 (at McKesson 2002–2017) | Led multi‑billion‑dollar negotiations; facilitated M&A; new business development |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Various community/non‑profit and educational initiatives | Board/leadership, campaign chair, guest lecturer | Not specified | Chaired capital campaigns; instituted scholarships; led disaster relief; university guest lecturing |
Board Governance
| Attribute | 2024 | 2025 | Notes |
|---|---|---|---|
| Independence | Independent director | Independent director | Listed “x” as independent in committee matrix |
| Committees | Compensation Committee member; Governance & Nominating Committee Chair | Audit Committee member; Governance & Nominating Committee Chair | Role shifted from Compensation to Audit between 2024–2025 |
| Committee meetings (Board‑wide) | Audit: 3 meetings (2024) ; Compensation: 4 (2024) ; Governance & Nominating: 2 (2024) | — | Meeting counts disclosed at committee level; individual attendance not disclosed |
| Executive sessions | Non‑management directors meet in executive session each quarterly board meeting | — | Governance practice noted in proxy |
| Annual meeting attendance policy | No policy regarding director attendance at annual meetings | — | Policy disclosure |
| Audit Committee Financial Expert | — | Watters designated as A.C. Financial Expert | Not Alexander |
Fixed Compensation
| Component | Structure | Alexander – FY2024 Amount |
|---|---|---|
| Annual cash retainer | $36,000, payable monthly | $36,000 |
| Annual committee fee (for any committee service) | $5,000, payable annually | $5,000 |
| Total cash fees (FY2024) | Retainer + committee fee | $41,000 |
Performance Compensation
| Equity Type | Grant Date | Shares/Options | Exercise/Strike | Vesting | Grant‑date Fair Value | Notes |
|---|---|---|---|---|---|---|
| Stock options (NED grant) | Sep 26, 2024 | 1,447 options (outstanding at 12/31/2024) | $17.00 per share (post 1‑for‑25 reverse split) | Fully vested on grant date | $3,618 (ASC 718) | Other NEDs received similar fully‑vested options |
Performance metrics tied to director compensation (FY2024): None disclosed. Directors received cash retainers/fees and fully vested stock options; no RSUs/PSUs or metric‑based pay elements were reported .
| Metric | Disclosed? | Details |
|---|---|---|
| TSR, revenue, EBITDA, ESG goals for director pay | No | No performance metrics tied to director compensation disclosed |
Other Directorships & Interlocks
| Category | Disclosure |
|---|---|
| Other current public company boards | None disclosed for Mr. Alexander in IVP’s 2025 and 2024 proxy materials |
| Committee roles at other public companies | None disclosed |
| Potential interlocks (competitors/suppliers/customers) | Not identified in proxy disclosures; no related‑party transaction involving Mr. Alexander reported |
Expertise & Qualifications
- Operations and growth leadership across Fortune 5, private equity, non‑profit, and private firms; experience leading multi‑billion‑dollar negotiations, M&A facilitation, and new business development .
- Governance roles: Chair, Governance & Nominating Committee; member, Audit Committee (2025). Prior member, Compensation Committee (2024) .
- Education: B.S., Industrial Distribution, Texas A&M University (May 2002) .
Equity Ownership
| As of Date | Class | Beneficially Owned Shares | Percent Outstanding | Notes |
|---|---|---|---|---|
| Oct 14, 2025 | Class A | 1,448 | <1% | Includes rights to acquire shares within 60 days, per SEC beneficial ownership rules |
| Oct 14, 2025 | Class B | — | — | — |
| Dec 31, 2024 | Options outstanding | 1,447 (all vested) | — | Director option grant on 9/26/2024; exercise price $17.00 |
| Jun 26, 2024 | Class A | 10 | <1% | Pre‑option‑grant snapshot |
Insider reporting and trades
- Section 16(a) compliance: One Form 4 was filed late for Mr. Alexander reporting the option grant; Company attributes late filings to administrative error .
Governance Assessment
Key findings
- Independence and committee leadership: Alexander is an independent director who chairs the Governance & Nominating Committee and sits on Audit (strong governance exposure) . Prior service on Compensation demonstrates cross‑committee experience .
- Engagement signals: Board conducted regular executive sessions each quarter; committee activity disclosed (Audit 3, Compensation 4, Governance & Nominating 2 meetings in 2024). Individual attendance rates were not disclosed .
- Pay alignment: Director pay is modest (cash retainer $36k + $5k committee) with a small, fully‑vested option grant (fair value $3,618), yielding total FY2024 compensation of $44,618 for Alexander. Fully‑vested, one‑day options for NEDs reduce long‑term retention features versus multi‑year vesting, but scale is small .
- Ownership: Beneficial ownership is de minimis (<1%); options outstanding of 1,447 support some alignment but limited “skin‑in‑the‑game” at current levels .
Potential red flags and mitigants
- RED FLAG: Late Section 16 filing (Form 4) for the option grant—explained as administrative error (process weakness; usually low‑severity but notable for governance hygiene) .
- Consideration: Director equity awards are fully vested at grant (less retentive and performance‑oriented than multi‑year vesting/PSUs). However, dollar amounts are small, and cash/equity mix is conservative .
- Related‑party exposure: No Mr. Alexander‑specific related‑party transactions disclosed; Audit Committee oversees such matters per policy .
Overall implication for investor confidence
- Alexander’s multi‑industry operating background and committee leadership (G&N Chair; Audit member) support Board effectiveness in oversight of governance and risk. The primary watch item is administrative rigor around insider filings and consideration of stronger long‑term equity alignment for non‑employee directors (e.g., multi‑year vesting), though current pay levels are modest .